In my latest What’s New solo episode, I’m diving into:
✅ Breakthrough drugs giving blood cancer patients longer remissions
✅ A 12-year-old’s inspiring story of targeted therapy success
✅ CAR-T therapies expanding into ovarian cancer
✅ New prostate cancer screening guidelines
✅ The rise of precision medicine & theranostics
✅ Futuristic innovations like synthetic drug factories inside the body 🤯
💪 Research is moving fast, and awareness saves lives. Tune in to learn, get inspired, and spread the hope.#LetsTalkFnCancer #CancerAwarenessMonth #CancerResearch #Podcast #CancerBreakthroughs
sources:
Highlights in this episode:
Blood cancers: Eli Lilly’s Jaypirca helps CLL/SLL patients live longer without progression; CAR-T therapy delivers remission for aggressive lymphoma 【web†source】.
Childhood cancer: A 12-year-old’s brain tumor stabilized after a targeted melanoma drug via the ZERO program in Sydney 【web†source】.
Gynecologic & ovarian cancers: CAR-T therapy expands into solid tumors; Eli-002 cancer vaccine shows strong KRAS-targeted immune responses 【web†source】.
Prostate cancer: Proposed guidelines could lower PSA screening age to 40, paired with MRI for more precise detection 【web†source】.
Thyroid cancer: Theranostics—blending diagnostics and therapy—emerges as a precision medicine frontier 【web†source】.
Broader innovations: New immunotherapies, remote clinical trials, synthetic drug factories, and research to prevent recurrence in breast cancer 【web†source】.
Podden och tillhörande omslagsbild på den här sidan tillhör
Colette Hoang. Innehållet i podden är skapat av Colette Hoang och inte av,
eller tillsammans med, Poddtoppen.